NIAID Banner Logo Image

HIV Citations List: August 2023

Literature Citations

1. Discovery of Novel Sulfonamide Substituted Indolylarylsulfones as Potent HIV-1 Inhibitors with Better Safety Profiles. Gao, S., L. Song, Y. Cheng, F. Zhao, D. Kang, S. Song, M. Yang, B. Ye, W. Zhao, Y. Tang, E. De Clercq, C. Pannecouque, P. Zhan, and X. Liu. Acta Pharmaceutica Sinica B, 2023. 13(6): p. 2747-2764. PMID[37425059]. PMCID[PMC10326263].
[PubMed]. HIV_08_2023.

2. Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity against an In Vitro Model of Latent HIV. Ghofrani, J., A. Bowen, J. Chen, P.B. Balakrishnan, A.B. Powell, K. Cherukula, C.R.Y. Cruz, R.B. Jones, R.M. Lynch, E.E. Sweeney, and R. Fernandes. International Journal of Nanomedicine, 2023. 18: p. 4055-4066. PMID[37520301]. PMCID[PMC10386837].
[PubMed]. HIV_08_2023.

3. 4'-Ethynyl-2'-deoxy-2'-β-fluoro-2-fluoroadenosine: A Highly Potent and Orally Available Clinical Candidate for the Treatment of HIV-1 Infection. Hou, J., Y. Peng, B. Liu, Q. Zhang, J.H. Wang, W. Yu, and J. Chang. Journal of Medicinal Chemistry, 2023. 66(16): p. 11282-11293. PMID[37535016].
[PubMed]. HIV_08_2023.

4. Withania somnifera Extracts Induced Attenuation of HIV-1: A Mechanistic Approach to Restrict Viral Infection. Jadaun, P., R. Harshithkumar, S.Y. Gaikwad, C. Seniya, S. Borse, A.A. Gawai, P. Chavan-Gautam, G. Tillu, and A. Mukherjee. Virology Journal, 2023. 20(1): p. 173-196. PMID[37537596]. PMCID[PMC10401819].
[PubMed]. HIV_08_2023.

5. Discovery of Novel Diarypyrimidine Derivatives Bearing Six-membered Non-aromatic Heterocycles as Potent HIV-1 NNRTIs with Improved Anti-resistance and Drug-like Profiles. Jiang, X., B. Huang, W.A. Zalloum, C.H. Chen, X. Ji, Z. Gao, J. Dai, M. Xie, D. Kang, E. De Clercq, C. Pannecouque, X. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2023. 258: p. 115605-115619. PMID[37393790].
[PubMed]. HIV_08_2023.

6. The Topoisomerase II β-kinase Associated with HIV-1 Is a Potential Target for Pyridine-bischalcones' anti-HIV-1 Activity. Kammari, K., K. Devaraya, S. Swain, and A.K. Kondapi. European Journal of Medicinal Chemistry, 2023. 259: p. 115623-115634. PMID[37473689].
[PubMed]. HIV_08_2023.

7. Identification of a Non-Nucleoside Reverse Transcriptase Inhibitor against Human Immunodeficiency Virus-1. Kim, M.J., K.L. Yu, R. Han, Y. Lee, K. Oh, and J.C. You. ACS Infectious Diseases, 2023. 9(8): p. 1582-1592. PMID[37415514].
[PubMed]. HIV_08_2023.

8. HIV-1 Integrase Inhibition Activity by Spiroketals Derived from Plagius flosculosus, an Endemic Plant of Sardinia (Italy) and Corsica (France). Sanna, C., B. D'Abrosca, A. Fiorentino, F. Giammarino, I. Vicenti, A. Corona, A. Caredda, E. Tramontano, and F. Esposito. Pharmaceuticals, 2023. 16(8): p. 1-13. PMID[37631033]. PMCID[PMC10457970].
[PubMed]. HIV_08_2023.

9. Greener Approach for the Isolation of Oleanolic Acid from Nepeta leucophylla Benth. Its Derivatization and Their Molecular Docking as Antibacterial and Antiviral Agents. Sharma, A., D. Kathuria, B. Kolita, A. Gohain, A.K. Das, G. Bhardwaj, and J. Simal-Gandara. Heliyon, 2023. 9(8): p. 18639-18651. PMID[37560655]. PMCID[PMC10407133].
[PubMed]. HIV_08_2023.

10. Exploring Antiviral Potency of N-1 Substituted Pyrimidines against HIV-1 and Other DNA/RNA Viruses: Design, Synthesis, Characterization, ADMET Analysis, Docking, Molecular Dynamics and Biological Activity. Srivastava, R., S.K. Gupta, F. Naaz, P.S. Sen Gupta, M. Yadav, V.K. Singh, S.K. Panda, S. Biswal, M.K. Rana, S.K. Gupta, D. Schols, and R.K. Singh. Computational Biology and Chemistry, 2023. 106: p. 107910-107924. PMID[37422940].
[PubMed]. HIV_08_2023.

11. Melanin Production by the Medicinal Mushroom Inonotus obliquus F-1375 in Submerged Liquid Cultivation and Its Antiretroviral Properties. Teplyakova, T.V., N.A. Markovich, N.M. Gashnikova, and M.P. Gashnikova. Applied Biochemistry and Microbiology, 2023. 59(4): p. 482-488. ISI[001049277000010].
[WOS]. HIV_08_2023.

12. Anti-HIV Crotocascarin Ω from Kenyan Croton dichogamus. Terefe, E.M., F.A. Okalebo, S. Derese, J. Muriuki, E. Mas-Claret, and M.K. Langat. Natural Product Research, 2023. 37(17): p. 2809-2816. PMID[36278900].
[PubMed]. HIV_08_2023.

13. A Toxin-conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-reversing Agent-reactivated Latent Cells. Wang, X., W. Xu, Z. Liu, Y. Wu, Q. Wang, M. Cao, T. Ying, N. He, L. Lu, and S. Jiang. mBio, 2022. 13(1): p. 1-17. PMID[35038908]. PMCID[PMC8764533].
[PubMed]. HIV_08_2023.

14. The Use of CBD and Its Synthetic Analog HU308 in HIV-1-infected Myeloid Cells. Williams, A., P. Khatkar, H. Branscome, Y. Kim, J. Erickson, M.A. Jenabian, C.T. Costiniuk, and F. Kashanchi. Pharmaceuticals, 2023. 16(8): p. 1147-1166. PMID[37631062]. PMCID[PMC10458222].
[PubMed]. HIV_08_2023.

15. Synthesis and Biological Evaluation of Simplified Ansellone Analogues with Lipophilic Side Chains as HIV Latency-reversing Agents. Yanagihara, M., N. Kishimoto, K. Nakahara, T. Abe, S. Miura, B. Lin, M. Fumimoto, J. Haruta, S. Misumi, M. Arisawa, and K. Murai. Chemistry, 2023. 29(44): p. 1-13. PMID[37217452].
[PubMed]. HIV_08_2023.

16. Xanthones with Potential Anti-inflammatory and anti-HIV Effects from the Stems and Leaves of Cratoxylum cochinchinense. Zhang, Y., J.M. Guo, M.M. Zhang, R. Wang, C.H. Liang, Y.M. Zhao, Y.Y. Deng, Y.P. Liu, and Y.H. Fu. Molecules, 2023. 28(16): p. 6050-6060. PMID[37630303]. PMCID[PMC10458312].
[PubMed]. HIV_08_2023.

17. Scopoletin Reactivates Latent HIV-1 by Inducing NF-κB Expression without Global T Cell Activation. Zhu, Y., Z. Jiang, L. Liu, X. Yang, M. Li, Y. Cheng, J. Xu, C. Yin, and H. Zhu. International Journal of Molecular Sciences, 2023. 24(16): p. 12649-12663. PMID[37628826]. PMCID[PMC10454185].
[PubMed]. HIV_08_2023.

Patent Citations

This month, no relevant HIV patents were identified.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024